Stephen W Horgan

Title: The Innovations of Stephen W. Horgan

Introduction

Stephen W. Horgan is a notable inventor based in Cincinnati, OH. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Horgan has developed "Tetrahydro and imidazoline antisecretory compounds." These compounds are characterized by a specific formula that includes pharmaceutically acceptable salts, diastereomers, and individual optical isomers. Another significant patent is for the "Process for preparing 2-(2,2-dicyclohexylethyl)piperidine." This process involves the catalytic hydrogenation of 2-(2,2-diphenylethenyl)pyridine, yielding high results with the use of a rhodium-supported catalyst.

Career Highlights

Horgan's career has been marked by his role at Richardson-Merrell Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical chemistry and has the potential to impact various medical treatments.

Collaborations

Throughout his career, Horgan has collaborated with notable colleagues, including Frank P. Palopoli and Robert W. Fleming. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking compounds.

Conclusion

Stephen W. Horgan's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for future innovations in medical treatments.